From October 1, 2023 to December 31, 2023, the company has repurchased 4,329,000 shares, representing 3.08% for $225.59 million. With this, the company has completed the repurchase of 9,371,000 shares, representing 8.1% for $474.77 million under the buyback announced on March 12, 2020.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
62.7 USD | -1.65% | +21.97% | +17.55% |
05-13 | Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating | MT |
05-10 | Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.55% | 8.61B | |
-6.00% | 182B | |
+1.57% | 111B | |
-3.77% | 68.48B | |
+0.36% | 49.69B | |
+7.46% | 44.46B | |
+2.33% | 40.67B | |
+22.64% | 31.22B | |
+1.31% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.